Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07100184
What this trial is testing

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

Who this might be right for
HER2-expressing High-risk or Very High-risk NMIBC Without Visible Foci of Disease After TURBT
Peking University First Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02371447
What this trial is testing

VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Swiss Cancer Institute 39
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464145
What this trial is testing

NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more
Relmada Therapeutics, Inc. 393
Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Early research (Phase 1)Study completedNCT05085977
What this trial is testing

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 12
Not applicableLooking for participantsNCT07182045
What this trial is testing

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

Who this might be right for
MyomaSurgery
The University of Texas Health Science Center, Houston 120
Large-scale testing (Phase 3)Looking for participantsNCT07804056
What this trial is testing

Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer (NMIBC)
Hamlet Pharma AB 194
Testing effectiveness (Phase 2)Study completedNCT00749892
What this trial is testing

Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer

Who this might be right for
Recurrent Bladder Urothelial CarcinomaRecurrent Renal Pelvis Urothelial CarcinomaRecurrent Ureter Urothelial Carcinoma+17 more
M.D. Anderson Cancer Center 34
Early research (Phase 1)Study completedNCT00782587
What this trial is testing

Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Halozyme Therapeutics 14
Large-scale testing (Phase 3)WithdrawnNCT07551544
What this trial is testing

ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
NMIBC
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT03892642
What this trial is testing

Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Oklahoma 18
Not applicableLooking for participantsNCT06765642
What this trial is testing

The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.

Who this might be right for
StrokeStroke PatientsArm Weakness as a Consequence of Stroke+6 more
Duke University 26
Large-scale testing (Phase 3)Ended earlyNCT01200992
What this trial is testing

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder NeoplasmNeoplasm Recurrence, LocalTransitional Cell, Carcinoma+2 more
Bioniche Life Sciences Inc. 84
Not applicableLooking for participantsNCT07494864
What this trial is testing

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

Who this might be right for
Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder EmptyingAsymptomatic Bacteriuria in Subjects Relying on Some Type of CatheterRecurrent Non-catheter Associated UTIs+5 more
University of Zurich 800
Not applicableUnknownNCT05110677
What this trial is testing

Pilot Study of Topographic Imaging of the Calf Muscle in Patients With PAD Using 3D Reconstruction of MSOT Images

Who this might be right for
Peripheral Vascular DiseasesPeripheral Arterial Disease
University Hospital Erlangen 9
Post-approval studies (Phase 4)Looking for participantsNCT05962541
What this trial is testing

Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)

Who this might be right for
Non-muscle-invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial CarcinomaHigh Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
University of Roma La Sapienza 327
Large-scale testing (Phase 3)Looking for participantsNCT06960577
What this trial is testing

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Who this might be right for
Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800507
What this trial is testing

Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer

Who this might be right for
NMIBC
Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03636256
What this trial is testing

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more
NanOlogy, LLC 36
Testing effectiveness (Phase 2)Study completedNCT02015104
What this trial is testing

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 32
Next Page